CELLULAR AND MOLECULAR LIFE SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2022-01-25 NJMU-CNS

1月4日提交，1月7号送审，1月25号minor revision.

56 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2022-03-15 ms9000000615443695

偏重的研究方向：靶点;肝脏;药物
经验分享：今天刚投稿，期待与好的结果

47 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2021-12-27 MS54455111222

审稿人怎么利用关键词审稿？

85 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

引言怎么写？

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2021-09-26 ms3000001738384174

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：核膜;血管新生
经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。
审稿速度正常，投稿到有review意见1个半月。
两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。
所以感觉对国人不太友好。

60 0

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2021-09-01 1223a67dm56(暂无昵称)

没投过

59 0

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2021-06-01 zzzzfffvvv

需要交钱 3860美元。

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2021-05-15 科研小麻瓜

投稿命中率:5.0
经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿

71 0

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2021-05-15 科研小麻瓜

还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中

53 0

[GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055110, encodeId=4df21055110f6, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：核膜;血管新生 经验分享：做蛋白新表型研究的，也有敲除动物，个人觉得做得蛮全面的，就是深度可能不够。 审稿速度正常，投稿到有review意见1个半月。 两个review细致专业，给的意见估计是大修，第二个review明显态度很积极。一共5页审稿意见，有一些也不难补，有一些是表述问题，不需要补实验。但editor估计没仔细看，就觉得要补的太多，没给机会。 所以感觉对国人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 20:54:06 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013517, encodeId=59fd101351e6a, content=没投过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb672316488, createdName=1223a67dm56(暂无昵称), createdTime=Wed Sep 01 17:06:03 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965834, encodeId=ae2396583487, content=投稿命中率:5.0 经验分享：个人认为投综述和通讯作者档次关系很大，比较厉害的通讯作者即使文章一般也容易中，反之容易一周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:20:14 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965835, encodeId=09e696583584, content=还算快，一般一周出结果，送外审或者拒稿，收综述很多，看前面评论说对中国人不友好，其实不是不友好，如果你导师是比较牛的人，发过大文章，你去写综述就更容易中，如果通讯作者是比较普通的就很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Sat May 15 14:26:41 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813033, encodeId=a6e7813033ce, content=请问这个杂志多久给编辑呢？已经十多天还在journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJEuTXQFRwicHPePb9Sr86bvtkE4zibxl4rdic920x2LibCZpEkNqV6pt8LFnM7TKZJhy4ZsGd5WxHjQ/132, createdBy=d9a02331642, createdName=繁星啊麦田啊, createdTime=Tue Aug 25 14:08:35 CST 2020, time=2020-08-25, status=1, ipAttribution=)]

2020-08-25 繁星啊麦田啊

请问这个杂志多久给编辑呢？已经十多天还在journal

150 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务